NCT03150459 - Simvastatin Plus Rifaximin in Decompensated Cirrhosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 26, 2017

Primary Completion Date

March 12, 2018

Study Completion Date

March 12, 2018

Conditions

Cirrhoses, Liver

Interventions

DRUG

Simvastatin 20 mg

Simvastatin 20 mg/day for 12 weeks (Group 1)

DRUG

Simvastatin 40mg

Simvastatin 40 mg/day for 12 weeks (Group 2)

DRUG

Rifaximin 400 mg

Rifaximin 400 mg/8 hours for 12 weeks (Group 1 and 2)

OTHER

Placebo of Simvastatin

Placebo of Simvastatin for 12 weeks (Group 3)

OTHER

Placebo of Rifaximin

Placebo of Rifaximin for 12 weeks (Group 3)

Trial Locations (9)

10129

San Giovanni Battista Hospital, Torino

35128

Padova University Hospital, Padua

53127

Universitatsklinikum Bonn, Bonn

92110

Beajuon Hospital, Clichy

Unknown

Bologna University Hospital, Bologna

1105 AZ

Academic Medical Centre, Amsterdam

08035

Hospital Universitari Vall d'Hebrón, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

NW3 2QG

Royal Free Hospital, London

All Listed Sponsors

lead

Judit Pich

OTHER